Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
- Products
-
- Ciprofloxacin Tablets
- Where it was sold
-
US Nationwide
Nationwide
- Units affected
- 20,335 bottles
- About this recall
- Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50